带面罩的呼气控制装置治疗慢性阻塞性肺疾病的临床观察

发布时间：2018-02-27 23:52

本文关键词： 慢性阻塞性肺疾病面罩外源性呼气末正压缩唇呼吸通气功能　出处：《实用医学杂志》2017年13期 　论文类型：期刊论文

【摘要】：目的检验笔者自行研制的带面罩的呼气控制装置治疗慢性阻塞性肺疾病(COPD)的疗效。方法接受带面罩的呼气控制装置治疗的102例患者中50例患者使用该装置的呼气末正压功能治疗,另外52例患者使用该装置的呼气延阻功能治疗,观察治疗前后患者动脉血气分析中二氧化碳分压(PaCO_2)、氧分压(PaO_2)、pH值及肺功能中用力肺活量(FVC)、一秒量(FEV1)、潮气量(VT)差异。结果(1)呼气末正压治疗组治疗前后肺功能FVC、FEV1、VT(2.95±0.32)L vs(3.22±0.35)L,(1.88±0.17)L vs(2.00±0.15)L,(335.28±43.59)mL vs(364.64±44.28)mL(均P0.01)差异有统计学意义;动脉血PaCO_2,PaO_2,pH(50.42±4.77)mmHg vs(48.42±3.76)mmHg,(65.42±4.60)mmHg vs(68.50±4.69)mmHg,(7.35±0.030)vs(7.37±0.037)(均P0.05)差异有统计学意义;(2)呼气延阻治疗组治疗前后肺功能FVC、FEV1、VT(2.93±0.22)L vs(3.10±0.27)L,(1.83±0.14)L vs(1.91±0.16)L,(335.48±44.16)mL vs(362.46±38.66)mL(均P0.05)差异有统计学意义;动脉血PaCO_2,PaO_2,pH(52.39±3.37)mmHg vs(50.06±3.92)mmHg,(68.05±3.80)mmHg vs(68.99±4.57)mmHg,(7.34±0.035)vs(7.37±0.036)(均P0.05)差异有统计学意义。结论带面罩的呼气控制装置能够改善COPD患者通气功能,使用方便、安全有效,具有较高的临床应用价值。
[Abstract]:Objective to evaluate the efficacy of the masked breath control device in the treatment of chronic obstructive pulmonary disease (COPD). Methods 50 out of 102 patients treated with mask expiratory control device were treated with the device. End positive pressure therapy, Another 52 patients were treated with the device's expiratory delay function. Observe the difference of Paco _ 2, Pao _ (2), Pao _ (2 +) pH value and forced vital capacity in pulmonary function in arterial blood gas analysis before and after treatment, at 1 second, FEV _ (1) and tidal volume (V _ T). Results: before and after treatment with positive end-expiratory pressure, the pulmonary function of the treatment group was 2.95 卤0.32 L vs(3.22 卤0.35 L vs(3.22 卤0.35 L (1.88 卤0.17) L vs(2.00 卤43.59 mL / L. The difference of vs(364.64 卤44.28 mL (all P 0.01) was statistically significant. The pH value of Paco _ 2 + Pao _ 2 was 50.42 卤4.77 mm Hg vs(48.42 卤3.76 mm vs(48.42 卤6.60 卤4.69 mm vs(68.50 卤4.69 mm vs(48.42 卤4.69 卤7.35 卤0.030 卤0.037 卤7.37 卤0.037 卤7.37 卤0.037 (P0.05). There was a significant difference in the pulmonary function of the two groups before and after treatment (P < 0.05). The pulmonary function of the group with delayed expiratory delay was 2.93 卤0.22L vs(3.10 卤0.27L 1.83 卤0.14L vs(1.91 卤0.16L vs(1.91 卤34.16ml vs(362.46 卤38.66mL (all P50.05). The pH value of Paco _ 2 + Paco _ 2 in arterial blood was 52.39 卤3.37 vs(50.06 卤3.92mHg vs(50.06 卤3.92nHg, 68.05 卤3.80mmHg vs(68.99 卤4.57mmHg vs(68.99 卤4.57mm vs(68.99 卤7.37 卤0.036m (all P 0.05). Conclusion the ventilatory control device with mask can improve the ventilation function of COPD patients, it is convenient, safe and effective, and has high clinical application value. [WT5 "HZ] [WT5BZ] [WT5BZ] [WT5BZ] [WT5" BZ] [WT5 "BZ] [WT5" BZ] there is a significant difference between the two groups (P < 0.05).
【作者单位】：天津市胸科医院呼吸与危重症科;
【分类号】：R563.9

【参考文献】